Apr 1, 2019 1:14 pm EDT CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
Mar 18, 2019 8:00 am EDT CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics
Mar 11, 2019 7:00 am EDT Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks
Feb 19, 2019 6:00 am EST CollPlant Announces Approval of Its rhCollagen Manufacturing Facility by European Union Notified Body
Dec 10, 2018 9:04 am EST Clinical Trial Published in the Journal of Shoulder and Elbow Surgery Concludes That CollPlant's Vergenix™ STR Effectively Demonstrates Significant Clinical Improvements in Tennis Elbow
Nov 29, 2018 8:07 am EST CollPlant Reports Third Quarter 2018 Financial Results and Provides Business Update
Nov 12, 2018 6:00 am EST CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
Oct 22, 2018 4:00 am EDT CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
